Alternative chelator for ⁸⁹Zr radiopharmaceuticals: radiolabeling and evaluation of 3,4,3-(LI-1,2-HOPO). - Wikidata - wikimedia - TriplyDB

Alternative chelator for ⁸⁹Zr radiopharmaceuticals: radiolabeling and evaluation of 3,4,3-(LI-1,2-HOPO).

Alternative chelator for ⁸⁹Zr radiopharmaceuticals: radiolabeling and evaluation of 3,4,3-(LI-1,2-HOPO).

http://www.wikidata.org/entity/Q33761754

about

Evaluation of macrocyclic hydroxyisophthalamide ligands as chelators for zirconium-89 Tripodal tris(hydroxypyridinone) ligands for immunoconjugate PET imaging with (89)Zr(4+): comparison with desferrioxamine-B.Novel (89)Zr cell labeling approach for PET-based cell trafficking studies New insights into structure and luminescence of Eu(III) and Sm(III) complexes of the 3,4,3-LI(1,2-HOPO) ligand.Novel Bifunctional Cyclic Chelator for (89)Zr Labeling-Radiolabeling and Targeting Properties of RGD Conjugates Di-macrocyclic terephthalamide ligands as chelators for the PET radionuclide zirconium-89.Optimization of the Sensitization Process and Stability of Octadentate Eu(III) 1,2-HOPO Complexes Preparation of 3-benzyloxy-2-pyridinone functional linkers: Tools for the synthesis of 3,2-hydroxypyridinone (HOPO) and HOPO/hydroxamic acid chelators.Evaluation of a 3-hydroxypyridin-2-one (2,3-HOPO) Based Macrocyclic Chelator for (89)Zr(4+) and Its Use for ImmunoPET Imaging of HER2 Positive Model of Ovarian Carcinoma in Mice.In Vitro and In Vivo Comparison of Selected Ga-68 and Zr-89 Labelled Siderophores.ImmunoPET Imaging of Insulin-Like Growth Factor 1 Receptor in a Subcutaneous Mouse Model of Pancreatic Cancer.p-SCN-Bn-HOPO: A Superior Bifunctional Chelator for (89)Zr ImmunoPET Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for 89Zr-immuno-PET Zirconium tetraazamacrocycle complexes display extraordinary stability and provide a new strategy for zirconium-89-based radiopharmaceutical development.A nuclear chocolate box: the periodic table of nuclear medicine.Radiometals: towards a new success story in nuclear imaging?In vivo imaging with antibodies and engineered fragments.Evaluation of DFO-HOPO as an octadentate chelator for zirconium-89.Exploiting the biosynthetic machinery of Streptomyces pilosus to engineer a water-soluble zirconium(iv) chelator.Current advances in ligand design for inorganic positron emission tomography tracers (68)Ga, (64)Cu, (89)Zr and (44)Sc.Radiolabelled Polymeric Materials for Imaging and Treatment of Cancer: Quo Vadis?A Practical Guide on the Synthesis of Metal Chelates for Molecular Imaging and Therapy by Means of Click Chemistry.Investigation of the complexation of natZr(iv) and 89Zr(iv) by hydroxypyridinones for the development of chelators for PET imaging applications.The bioconjugation and radiosynthesis of 89Zr-DFO-labeled antibodies An octadentate bifunctional chelating agent for the development of stable zirconium-89 based molecular imaging probes.Scaling-down antibody radiolabeling reactions with zirconium-89.Macrocycle-Based Hydroxamate Ligands for Complexation and Immunoconjugation of 89Zirconium for Positron Emission Tomography (PET) Imaging.89Zr-Immuno-Positron Emission Tomography in Oncology: State-of-the-Art 89Zr Radiochemistry.Multifunctional Desferrichrome Analogues as Versatile 89Zr(IV) Chelators for ImmunoPET Probe Development.Cyclic versus Noncyclic Chelating Scaffold for 89Zr-Labeled ZEGFR:2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression.Re-thinking the role of radiometal isotopes: Towards a future concept for theranostic radiopharmaceuticals.A new tetrapodal 3-hydroxy-4-pyridinone ligand for complexation of 89zirconium for positron emission tomography (PET) imaging.Chemical aspects of metal ion chelation in the synthesis and application antibody-based radiotracers.Iron Oxide Nanoradiomaterials: Combining Nanoscale Properties with Radioisotopes for Enhanced Molecular Imaging.Reassembly of 89 Zr-Labeled Cancer Cell Membranes into Multicompartment Membrane-Derived Liposomes for PET-Trackable Tumor-Targeted Theranostics.Synthesis and Evaluation of a Zr-89-Labeled Monoclonal Antibody for Immuno-PET Imaging of Amyloid-β Deposition in the Brain.A desferrioxamine B squaramide ester for the incorporation of zirconium-89 into antibodies.

P2860

Q33757834-4F22E566-8399-4301-A17A-ED7EBA53B738 Q35170338-FA838A32-0420-4F2C-9479-693983D662AB Q35462110-771C2442-F9F2-4C59-8A09-04327C711FB0 Q35610156-89905C9F-5DDC-40C2-91DD-845DDA8D92CC Q35676322-BEFA41B3-90BD-4E1B-92FB-B3CC9057F71B Q35865849-C88807DB-83FF-4F54-B323-057F1977CDFA Q36015186-DA63E5F8-5C30-478C-8DAF-3C55966C05E5 Q36333948-3A41E0CB-4265-46FB-ADAB-91EAF15BB826 Q36644332-D45E736C-4C5C-4F5E-94F3-21B29642F83C Q36909826-A8E1F754-559F-4224-A4FD-6CC8B79D5FFF Q36980480-0D831955-C750-4F75-8C61-C18E26E9F74E Q37129847-3546A317-204C-459F-A07D-849A97FF5D50 Q37560052-D016C834-3628-4197-854B-63686BCF8E1D Q37718007-CB0A1582-8173-4C10-9D81-42586CFC51E5 Q38269216-D0E2ABDB-BFE1-4BBC-9033-D413394C31BC Q38273277-DDFA27DF-5A85-4FD2-8985-1542F11ED9B9 Q38454458-DAC8C4E9-2AED-4DE1-A62E-93A9E654FD1F Q38658244-41233BC0-412E-439A-9016-5D15FEAD67E9 Q38709042-D7346FF3-FACD-4BCF-A622-DCB35CF888C5 Q38729041-80CFE595-31A8-48B6-B5C9-927DBEF63400 Q38755295-B66C0AD6-7E5A-4C8F-9C7E-A8DC0DB9CD6E Q38873357-B6A29A4B-48B5-442E-AFD8-D3E177FC24AF Q38880203-6EA4BD7A-BFDA-4C5F-9F3B-B377495DC209 Q38903311-FB011FD1-D046-43C0-981F-6E1108EF7D45 Q38965023-422E01DF-9610-4FDF-9083-5DFACDD0058A Q39912904-D9163B07-2632-4872-B70A-B2DF34AAEA9C Q41067900-A407D844-AD39-4272-BE67-60C41B49593D Q41690954-C13300E9-C8D2-4574-826D-F1AE96A57CA7 Q41728421-DD925F3E-ED8D-43A4-B8E4-2438C5CDEE78 Q47158578-7941C6A2-807C-4A2E-B6AC-726FF68A05F2 Q47588415-FF41029E-218C-4A3A-97EE-10059407D28A Q48118923-D301F155-5934-497B-9BFF-9AD9A510190B Q48136353-C4B22CDA-1937-4B5D-BA76-458C9B67967A Q48189789-6076706C-5562-498A-B3D8-ABD27ADECFE3 Q50071465-186C6C86-E2F5-4F98-92E6-72566C39E497 Q52144701-D094F584-DEE1-441D-A0DB-3B5047536641 Q52845355-3E527979-CA0E-4628-A7F4-8F7B5687442F

P2860

Alternative chelator for ⁸⁹Zr radiopharmaceuticals: radiolabeling and evaluation of 3,4,3-(LI-1,2-HOPO).

http://www.wikidata.org/entity/Q33761754

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Alternative chelator for ⁸⁹Zr ...... uation of 3,4,3-(LI-1,2-HOPO).

@ast

Alternative chelator for ⁸⁹Zr ...... uation of 3,4,3-(LI-1,2-HOPO).

@en

type

label

Alternative chelator for ⁸⁹Zr ...... uation of 3,4,3-(LI-1,2-HOPO).

@ast

Alternative chelator for ⁸⁹Zr ...... uation of 3,4,3-(LI-1,2-HOPO).

@en

prefLabel

Alternative chelator for ⁸⁹Zr ...... uation of 3,4,3-(LI-1,2-HOPO).

@ast

Alternative chelator for ⁸⁹Zr ...... uation of 3,4,3-(LI-1,2-HOPO).

@en

P1433

Q33761754-6984F656-2DF8-4F8D-806D-B9925546B4B7

P1476

Q33761754-FED8D64A-8B36-4D0B-8FCD-B0E8228D2E28

P2093

Q33761754-1A498BF9-EFE0-4C42-A8AC-91683A3471F4

Q33761754-41DBCF4E-8F91-461F-AFAA-8AD9F66ED542

Q33761754-6B5406C8-2EC4-4D25-9B6F-22634A47B7A7

Q33761754-9E58C693-9FF9-4894-B646-414D6DEBCAFE

Q33761754-AC279ADC-235E-42FC-9CF1-FA81550B4012

Q33761754-BECE6181-EB4E-431D-87FB-FBBC7D7047FA

Q33761754-FB5B7EAF-238F-48E8-A888-AB3138779993

P2860

Q33761754-046E675C-5946-4B92-B18A-23024B929723

Q33761754-0B0D7515-E857-4E28-BC93-81B9FFDB929C

Q33761754-0D630B59-633F-4806-BD6C-C5084B9E2C8A

Q33761754-13FE50AA-35A5-4AD3-B07E-53245EABE2A9

Q33761754-22CEBABB-33C3-4091-930C-4D78F0A7D99E

Q33761754-22D6D0A8-BA18-4B4D-8DFD-DB324D81CAFB

Q33761754-305DA265-E420-42FF-A854-C4B20339776A

Q33761754-3251D7CB-1922-42EE-AED8-F338D133DD2A

Q33761754-386F1009-1BA4-428F-9004-D7D4E228026C

Q33761754-38B38B72-A72E-4413-9C26-B3449144D844

P304

Q33761754-52757E5D-57D8-4134-A734-3875CAF6F391

P31

Q33761754-FC9219B1-F9E9-406C-8DF4-74D77F7F8706

P356

Q33761754-BD62313C-73F3-4084-9FBF-8710CC1326E4

P407

Q33761754-4C35A9EE-619F-4193-836D-777DC98C3392

P433

Q33761754-CB4F6D53-D93A-48FA-89EE-4754D0B39410

P478

Q33761754-E3FBE759-2E1C-4D5B-B429-55F540CB84D7

P577

Q33761754-BCEB5FF5-110C-4EEF-8C99-84F68BA7B740

P5875

Q33761754-48E923EA-00A5-4D58-B7DB-2CB53A0B2498

P698

Q33761754-548BCB8A-3D93-4B74-89B9-89E15EB4F68D

P932

Q33761754-467A7D68-55C9-409D-97FE-5495E6006B00

P356

P1433

Journal of Medicinal Chemistry

P1476

Alternative chelator for ⁸⁹Zr ...... uation of 3,4,3-(LI-1,2-HOPO).

@en

P2093

Brian M Zeglis

http://www.w3.org/2001/XMLSchema#string

Gabor Pohl

http://www.w3.org/2001/XMLSchema#string

J J Dannenberg

http://www.w3.org/2001/XMLSchema#string

Jason S Lewis

http://www.w3.org/2001/XMLSchema#string

Lynn C Francesconi

http://www.w3.org/2001/XMLSchema#string

Melissa A Deri

http://www.w3.org/2001/XMLSchema#string

Shashikanth Ponnala

http://www.w3.org/2001/XMLSchema#string

P2860

p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging

Standardized methods for the production of high specific-activity zirconium-89.

Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals.

89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo.

Applying PET to broaden the diagnostic utility of the clinically validated CA19.9 serum biomarker for oncology.

A comparison of the behavior of functional/basis set combinations for hydrogen-bonding in the water dimer with emphasis on basis set superposition error.

The next generation of positron emission tomography radiopharmaceuticals in oncology.

Rational design of sequestering agents for plutonium and other actinides.

PET and MRI of metastatic peritoneal and pulmonary colorectal cancer in mice with human epidermal growth factor receptor 1-targeted 89Zr-labeled panitumumab.

In vivo biodistribution and accumulation of 89Zr in mice.

P304

4849-4860

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/JM500389B

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262231058

http://www.w3.org/2001/XMLSchema#string

P698

24814511

http://www.w3.org/2001/XMLSchema#string

P932

4059252

http://www.w3.org/2001/XMLSchema#string